InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,493.20
(
0.07%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.08
(
-0.43%
)
Bitcoin
60,055.95
(
-3.18%
)
Post# of 722
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 85
Posts 32622
Boards Moderated 86
Alias Born 03/22/2005

gfp927z

Re: None

Monday, 02/13/2023 8:34:25 PM

Monday, February 13, 2023 8:34:25 PM

Post# of 722
>>> Axsome’s stock falls after disclosing Teva’s plans to market generic Auvelity


Market Watch

Feb. 13, 2023

By Jaimy Lee


https://www.marketwatch.com/story/axsomes-stock-falls-after-disclosing-tevas-plans-to-market-generic-auvelity-12d75af9?siteid=yhoof2


Shares of Axsome Therapeutics Inc. AXSM, -0.97% tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical Industries Ltd. TEVA, +0.39% is seeking approval from the Food and Drug Administration to market a generic version of Auvelity, Axsome’s depression treatment. Axsome’s stock has gained 95.8% over the past year, while the S&P 500 SPX, +1.14% declined 7.6%.

<<<



---
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up